ASCP Education Survey: Immune-Related Adverse Events
As part of an educational grant from Bristol-Myers Squibb, ASCP is developing an online tumor board simulation designed to increase knowledge and competence around the diagnosis, testing, reporting, and management of common immune-related adverse events (irAEs) in patients undergoing checkpoint inhibitor therapy, across the continuum of care.

We would love to hear about the challenges you face regarding irAEs, as well as possible topics or types of irAEs you would like to see addressed in this educational activity.

Thank you for sharing your thoughts to help shape the future of ASCP's online education.
What are the biggest challenges surrounding immune-related adverse events (irAEs) you face in your practice?
Your answer
What types of cases or irAEs would you like to see addressed in this educational program?
Your answer
What is your professional role?
Please enter your email address if you would like to be notified once this educational activity is available.
Your answer
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Privacy Policy